Cervantes-Madrid, D., Dominguez-Gomez, G., Gonzalez-Fierro, A., Perez-Cardenas, E., Taja-Chayeb, L., Trejo-Becerril, C., & Duenas-Gonzalez, A. (2017). Feasibility and antitumor efficacy in vivo, of simultaneously targeting glycolysis, glutaminolysis and fatty acid synthesis using lonidamine, 6-diazo-5-oxo-L-norleucine and orlistat in colon cancer. Oncol Lett.
Chicago Style CitationCervantes-Madrid, Diana, Guadalupe Dominguez-Gomez, Aurora Gonzalez-Fierro, Enrique Perez-Cardenas, Lucia Taja-Chayeb, Catalina Trejo-Becerril, i Alfonso Duenas-Gonzalez. "Feasibility and Antitumor Efficacy in Vivo, of Simultaneously Targeting Glycolysis, Glutaminolysis and Fatty Acid Synthesis Using Lonidamine, 6-diazo-5-oxo-L-norleucine and Orlistat in Colon Cancer." Oncol Lett 2017.
Cita MLACervantes-Madrid, Diana, et al. "Feasibility and Antitumor Efficacy in Vivo, of Simultaneously Targeting Glycolysis, Glutaminolysis and Fatty Acid Synthesis Using Lonidamine, 6-diazo-5-oxo-L-norleucine and Orlistat in Colon Cancer." Oncol Lett 2017.